Document is current
Any future updates will be listed below
-
Authors
Gray, Penelope https://orcid.org/0000-0001-9065-4734
Mariz, Filipe Colaço https://orcid.org/0000-0001-6624-4524
Eklund, Carina
Eriksson, Tiina
Faust, Helena
Kann, Hanna
Müller, Martin
Paavonen, Jorma
Pimenoff, Ville N. https://orcid.org/0000-0002-0813-7031
Sehr, Peter
Surcel, Heljä-Marja
Dillner, Joakim
Waterboer, Tim
Lehtinen, Matti
-
Funding
Funding for this research was provided by:
Cancerfonden
Stiftelsen för Strategisk Forskning (RB13-0011)
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 30 July 2024
First Online: 13 August 2024
Competing interests
: T.W. serves on an advisory board for Merck, Sharp & Dohme (MSD). M.L. has received grants for HPV vaccination studies from GSK Biologicals and Merck & Co. Inc. through his employer Tampere University. The authors have no conflicts of interest to disclose.
